ALS drug trials face setbacks but offer glimmers of hope
FierceBiotech - 07-Jan-2025Fosigotifator and DNL343 miss key goals, sparking calls for deeper analysis and longer studies
Join the club for FREE to access the whole archive and other member benefits.
Pharmaceutical research and development.
AbbVie is a global, research-driven biopharmaceutical company committed to developing innovative advanced therapies for some of the world’s most complex and critical conditions. The company’s mission is to use its expertise, dedicated people and unique approach to innovation to markedly improve treatments across four primary therapeutic areas: immunology, oncology, virology and neuroscience. In more than 75 countries, AbbVie employees are working every day to advance health solutions for people around the world.
Visit website: https://www.abbvie.com/
Details last updated 05-Mar-2020
Fosigotifator and DNL343 miss key goals, sparking calls for deeper analysis and longer studies
Aliada’s BBB technology aims to transform CNS drug delivery
Patients’ vision and retinal health remained stable after six months
Study reveals new insights into obesity, diabetes, and genetic diversity
ABBV-CLS-484 enhances anti-tumor immunity and is currently in clinical trials